Ocimum Labs manufactures high quality intermediates for global markets used by API manufacturers and fully integrated pharmaceutical companies. Ocimum Labs offers these intermediates at competitive prices adhering to the global standards including quality, GMP and documentation.
| S.No. | Being used in API | Intermediates Name | CAS number |
|---|---|---|---|
| 1 | Flavoxate hydrochloride | 3-Methylflavone -8-Carboxylic Acid | 3468-01-7 |
| 2 | 1-(2-Chloroethyl)-piperidine hydrochloride | 2008-75-5 | |
| 3 | Fluvoxamine maleate | 1-chloro-4-methoxybutane | 17913-18-7 |
| 4 | 4-(trifluoromethyl)benzonitrile | 455-18-5 | |
| 5 | 5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone | 61718-80-7 | |
| 6 | Olmesartan | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester | 144689-93-0 |
| 7 | Febuxostat | Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 |
| 8 | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 160844-75-7 | |
| 9 | Empagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
| 10 | (R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate | 219823-47-9 | |
| 11 | Dasatinib | 2-Chloro-6-Methylaniline | 87-63-8 |
| 12 | Carfilzomib | 4-Morpholinoacetic acid. HCl | 89531-58-8 |
| 13 | Olaparib | N-Boc-piperazine | 57260-71-6 |
| 14 | 2-Fluoro-5-formylbenzonitrile | 218301-22-5 | |
| 15 | Tofacitinib | Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| 16 | Vilazodone hydrochloride | 5-Nitrosalicylaldehyde | 97-51-8 |
| 17 | Dronedarone Hydrochloride | 2-n-Butyl-5-nitrobenzofuran | 133238-87-6 |
| 18 | (2-butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl) methanone | 141645-16-1 | |
| 19 | 2-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]-5-nitrobenzofuran | 141645-23-0 | |
| 20 | Montelukast, Dexketoprofen | 3-Bromoacetophenone | 2142-63-4 |
| 21 | Tedizolid | 2,5-dibromopyridine | 624-28-2 |
| 22 | 5-Bromo-2-Cyano Pyridine | 97483-77-7 |